cliquez sur les images pour les agrandir
" Bioflexible " protocols
Michèle Pelletier- Aouizérate
Bioflexible protocols mean several voices…
1 - Modulating the level of energy used for power density and dose . But also the sequence of wavelengths during illumination.
Thus, wound healing , mediators (cytokines ) are released by cytocytes ( fibroblasts , keratinocytes , mast cells , Merkel cells ) under the influence of an infinitesimal light dose and for a selective wavelength ; In visible range for such parameters as : Irradiance about 150 microwatt/cm2 for a dose of 450 micro joules/cm2 .
Glen Calderhead demonstrates the value of a prior PBM * yellow (590 nm). The keratinocytes release cytokines and prepare in a sequential irradiation manner 830nm deeper cellular components of the dermis.
He called this process The Microlevel Laser Therapy.
He remains faithful to the concept of Biphasic Dose Response Curve. The Arndt Shultz Curve (About in vitro studies...Indeed there are many effective thresholds).
One can imagine many specific "Tailoring» settings .... For the particular selective tropism wavelength on the target cells.
2 - The combination with other «Lasers light" procedures to mitigate their harmful thermal effect. Far from antinomic , PBM * Led is a guardian angel :calming and healing Laser process(the one in high energy):
Waxing , Treatment of couperosis , birthmarks , spider veins etc. . , Co2 laser ablative fractional resurfacing; Fractional ablative radiofrequency or microneedling (Forthcoming Presentations: Pablo Naranjo , G Calderhead). The list goes on.....
3 - The synergistic action of other molecules included in the cutaneous tissue (PRP, Mesotherapy) The concept of pro- activation takes part in. We must conceive that as distant relative: Ie Photodynamic therapy is a necessary and vital process we are not aware of.
Presentations: Linda Fouque and Isabella Tilszer
4 - Finally, Even modulation of the immune process and its corollary, inflammation (Already developed in a previous session Paris in December 2013) broadens the scope of investigation: The future of PBM *. As we look at beautiful autoimmune diseases clinical cases. Presentation: Suzanne Hausdorfer
Have a nice trip….
PBM *: Photobiomodulation
All presentations will be available on the website in their entirety